Rodolfo M - Search Results

1

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

Rodolfo M, Luksch R, Stockert E, Chen YT, Collini P, Ranzani T, Lombardo C, Dalerba P, Rivoltini L, Arienti F, Fossati-Bellani F, Old LJ, Parmiani G, Castelli C. Rodolfo M, et al. Cancer Res. 2003 Oct 15;63(20):6948-55. Cancer Res. 2003. PMID: 14583496

2

Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosourea on spontaneous metastases of a non-immunogenic murine tumour.

Acerbis G, Cleris L, Rodolfo M, Parmiani G, Formelli F. Acerbis G, et al. Among authors: rodolfo m. Cancer Immunol Immunother. 1992;34(6):383-8. doi: 10.1007/BF01741748. Cancer Immunol Immunother. 1992. PMID: 1563015 Free PMC article.

3

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.

Colombo MP, Ferrari G, Stoppacciaro A, Parenza M, Rodolfo M, Mavilio F, Parmiani G. Colombo MP, et al. Among authors: rodolfo m. J Exp Med. 1991 Apr 1;173(4):889-97. doi: 10.1084/jem.173.4.889. J Exp Med. 1991. PMID: 1706752 Free PMC article.

4

Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours.

Rodolfo M, Bassi C, Salvi C, Parmiani G. Rodolfo M, et al. Cancer Immunol Immunother. 1991;34(1):53-62. doi: 10.1007/BF01741325. Cancer Immunol Immunother. 1991. PMID: 1760812 Free PMC article.

5

Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells.

Rodolfo M, Salvi C, Bassi C, Rovetta G, Melani C, Colombo MP, Parmiani G. Rodolfo M, et al. Nat Immun Cell Growth Regul. 1991;10(6):308-19. Nat Immun Cell Growth Regul. 1991. PMID: 1787836

6

An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis.

Mazzocchi A, Rodolfo M, Parmiani G, Anichini A. Mazzocchi A, et al. Among authors: rodolfo m. Melanoma Res. 1991 Aug-Sep;1(3):169-76. Melanoma Res. 1991. PMID: 1841713

7

Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cells.

Gambacorti-Passerini C, Rivoltini L, Fizzotti M, Rodolfo M, Sensi ML, Castelli C, Orazi A, Polli N, Bregni M, Siena S, et al. Gambacorti-Passerini C, et al. Among authors: rodolfo m. Br J Haematol. 1991 Jun;78(2):197-205. doi: 10.1111/j.1365-2141.1991.tb04416.x. Br J Haematol. 1991. PMID: 2064957

8

Adoptive immunotherapeutic treatments with interleukin 2 and lymphocytes in a mouse colonic adenocarcinoma model.

Rodolfo M, Salvi C, Bassi C, Sensi M, Parmiani G. Rodolfo M, et al. Ann Ist Super Sanita. 1990;26(3-4):423-32. Ann Ist Super Sanita. 1990. PMID: 2091504

9

Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid.

Pratesi G, Rodolfo M, Rovetta G, Parmiani G. Pratesi G, et al. Among authors: rodolfo m. Eur J Cancer. 1990;26(10):1079-83. doi: 10.1016/0277-5379(90)90056-y. Eur J Cancer. 1990. PMID: 2148884

10

Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes. Survival benefit of adjuvant post-surgical treatments and comparison with experimental metastases model.

Rodolfo M, Salvi C, Bassi C, Parmiani G. Rodolfo M, et al. Cancer Immunol Immunother. 1990;31(1):28-36. doi: 10.1007/BF01742492. Cancer Immunol Immunother. 1990. PMID: 2306753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page